PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-08-16

Date Title Company
16-Aug-2023 Updated Data from TRIDENT-1 Trial Show Durable Efficacy Benefits with Repotrectinib for Patients with Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer Businesswire
16-Aug-2023 Vergent Bioscience to Present Phase 2 Clinical Data for VGT-309 at IASLC 2023 World Conference on Lung Cancer Businesswire
16-Aug-2023 Triage B-Type Natriuretic Peptide (BNP) Testing Market to Flourish at 8.50% CAGR and Surpass US$ 9.60 Billion by 2030 The Wire Times
16-Aug-2023 Biocytogen Announces Grand Opening of Waltham, MA Facility Businesswire
16-Aug-2023 Advanced Wound Care Market 2023: Predicted to Grow at CAGR of 4.6% by 2030, AMR The Wire Times
16-Aug-2023 Bioartificial Organ Manufacturing Market to Reach $42.03 Billion by the End of 2030 The Wire Times
16-Aug-2023 Hospital Acquired Disease Testing Market Is Forecast To Reach 35.92 Billion By 2030 The Wire Times
16-Aug-2023 The Fertility Partners Announces New CEO Businesswire
16-Aug-2023 Surgical Microscopes Market Report 2023: Share Will Increase at 8.6% CAGR Globally by 2030 | By AMR The Wire Times
16-Aug-2023 Procemsa Group continues its international development with the acquisition of Master Pharm Procemsa
16-Aug-2023 Procaps Group Publishes White Paper on Innovative Gummy Technology Businesswire
16-Aug-2023 SHAREHOLDER ALERT: Kaskela Law LLC Announces Stockholder Investigation of NRx Pharmaceuticals, Inc. and Encourages Long-Term NRXP / BRPA Investors to Contact the Firm Businesswire
16-Aug-2023 Medical Cannula Market Is Likely To Reach A Value Of 764.59 Million By 2030, With A CAGR Of 7.00% The Wire Times
16-Aug-2023 XponentL Data and Tamr Announce Strategic Partnership to Deliver Innovative Data Product Solutions Businesswire
16-Aug-2023 MEI Pharma Announces First Patient Dosed in Clinical Study Evaluating ME-344 Plus Bevacizumab (AVASTIN®) in Patients with Previously Treated Metastatic Colorectal Cancer Businesswire
16-Aug-2023 Seagen Phase 3 Trial of TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-trastuzumab emtansine Meets Primary Endpoint of Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer Businesswire
16-Aug-2023 National Cancer Institute (NCI) Director, Monica M. Bertagnolli, M.D., Selected as Recipient of the 2023 AIM-HI Beacon Award for Women Leaders in Oncology Businesswire
16-Aug-2023 NPWT Devices Market 2023 Trends: Revenue to Cross USD 3,347 Million by 2027 The Wire Times
16-Aug-2023 Approval secured for one of Europe’s largest Life Science campuses in Stevenage UBS Asset Management
16-Aug-2023 Multiple Myeloma Market is Projected to Grow Expeditiously: to Attain USD 53.52 Billion by 2031, Claims AMR The Wire Times